These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27152265)

  • 21. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro.
    Shankland SJ; Pippin JW; Couser WG
    Kidney Int; 1999 Aug; 56(2):538-48. PubMed ID: 10432393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Kurokawa K; Adler S; Johnson RJ; Couser WG
    Kidney Int; 1997 Dec; 52(6):1570-8. PubMed ID: 9407502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy.
    Thomas ME; Brunskill NJ; Harris KP; Bailey E; Pringle JH; Furness PN; Walls J
    Kidney Int; 1999 Mar; 55(3):890-8. PubMed ID: 10027925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal C3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion.
    Montinaro V; Lopez A; Monno R; Cappiello V; Manno C; Gesualdo L; Schena FP
    Kidney Int; 2000 Jan; 57(1):137-46. PubMed ID: 10620195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.
    Turnberg D; Lewis M; Moss J; Xu Y; Botto M; Cook HT
    J Immunol; 2006 Sep; 177(6):4094-102. PubMed ID: 16951374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.
    Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice.
    Ikeda Y; Horinouchi Y; Hamano H; Hirayama T; Kishi S; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Aihara KI; Nagasawa H; Tsuchiya K; Tamaki T
    Sci Rep; 2017 Sep; 7(1):10621. PubMed ID: 28878231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
    Gionanlis L; Alexopoulos E; Papagianni A; Leontsini M; Memmos D
    Ren Fail; 2008; 30(2):239-46. PubMed ID: 18300128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active Heymann nephritis in complement component C6 deficient rats.
    Leenaerts PL; Hall BM; Van Damme BJ; Daha MR; Vanrenterghem YF
    Kidney Int; 1995 Jun; 47(6):1604-14. PubMed ID: 7643529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury.
    van Timmeren MM; Gross ML; Hanke W; Klok PA; van Goor H; Stegeman CA; Bakker SJ
    Nephrol Dial Transplant; 2008 Dec; 23(12):3814-23. PubMed ID: 18653900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.
    He C; Imai M; Song H; Quigg RJ; Tomlinson S
    J Immunol; 2005 May; 174(9):5750-7. PubMed ID: 15843577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
    Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
    Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.
    Rangan GK; Wang Y; Tay YC; Harris DC
    Kidney Int; 1999 Jul; 56(1):118-34. PubMed ID: 10411685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells.
    Abe K; Li K; Sacks SH; Sheerin NS
    Clin Exp Immunol; 2004 Apr; 136(1):60-6. PubMed ID: 15030515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
    Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
    Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy.
    Stangou M; Alexopoulos E; Pantzaki A; Leonstini M; Memmos D
    Scand J Urol Nephrol; 2008; 42(4):373-80. PubMed ID: 19230171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria.
    Ikeda Y; Jung YO; Kim H; Oda T; López-Guisa J; Maruvada R; Diamond DL; Martin KJ; Wing D; Cai X; Eddy AA
    Nephron Exp Nephrol; 2004; 97(4):e123-35. PubMed ID: 15331933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of proteinuria on the kidney; proteinuria, renal enlargement, and renal injury consequent on protracted parenteral administration of protein solutions in rats.
    BAXTER JH; COTZIAS GC
    J Exp Med; 1949 Jun; 89(6):643-68. PubMed ID: 18129864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.